Paricalcitol and Endothelial Function in Chronic Kidney Disease (vol 64, pg 1005, 2014)

被引:1
|
作者
Zoccali, C.
Curatola, G.
Panuccio, V
Tripepi, R.
Pizzini, P.
Versace, M.
Bolignano, D.
Cutrupi, S.
Politi, R.
Tripepi, G.
Ghiadoni, L.
Thadhani, R.
Mallamaci, F.
机构
关键词
D O I
10.1161/HYP.0000000000000028
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:E48 / E48
页数:1
相关论文
共 50 条
  • [21] Does paricalcitol reduce proteinuria in patients with chronic kidney disease?
    Yoshiki Nishizawa
    Tetsuo Shoji
    Nature Clinical Practice Nephrology, 2006, 2 : 352 - 353
  • [22] Peripheral Endothelial Function and Cardiovascular Events in Chronic Kidney Disease
    Hirata, Yoshihiro
    Sugiyama, Seigo
    Yamamoto, Eiichiro
    Matsuzawa, Yasushi
    Akiyama, Eiichi
    Kusaka, Hiroaki
    Fujisue, Koichiro
    Kurokawa, Hirofumi
    Matsubara, Junichi
    Sugamura, Koichi
    Maeda, Hirofumi
    Iwashita, Satomi
    Jinnouchi, Hideaki
    Matsui, Kunihiko
    Ogawa, Hisao
    CIRCULATION, 2013, 128 (22)
  • [23] Endothelial function, CRP and oxidative stress in chronic kidney disease
    Annuk, M
    Soveri, I
    Zilmer, M
    Lind, L
    Hulthe, J
    Fellström, B
    JOURNAL OF NEPHROLOGY, 2005, 18 (06) : 721 - 726
  • [24] There Is No Impact of Diabetes on the Endothelial Function of Chronic Kidney Disease Patients
    Coutinho, Mariana Nogueira
    Carvalho, Aluizio Barbosa
    Dalboni, Maria Aparecida
    Mouro, Margaret Gori
    Suemitsu Higa, Elisa Mieko
    Costa-Hong, Valeria
    Bortolotto, Luiz Aparecido
    de Oliveira Figueiredo, Rejane Augusta
    Fernandes Canziani, Maria Eugenia
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [25] Resveratrol supplementation improves endothelial function in chronic kidney disease
    Gimblet, Colin
    Kruse, Nicholas
    Geasland, Katharine
    Mickelson, Jeni
    Sun, Mingyao
    Rehman, Safur
    Wendt, Linder
    Ten-Eyck, Patrick
    Ernst, Jackson
    Pierce, Gary
    Jalal, Diana
    PHYSIOLOGY, 2023, 38
  • [26] American Hustle (vol 24, pg 64, 2014)
    Stables, Kate
    SIGHT AND SOUND, 2014, 24 (04): : 111 - 111
  • [27] Chronic kidney disease: Should sodium intake be restricted in patients with CKD? (vol 10, pg 363, 2014)
    Burnier, Michel
    Wuerzner, Gregoire
    NATURE REVIEWS NEPHROLOGY, 2016, 12 (11) : 666 - 666
  • [28] Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial (vol 25, pg 175, 2014)
    Wang, A. Y.
    Fang, F.
    Chan, J.
    Wen, Y. Y.
    Qing, S.
    Chan, I. H.
    Lo, G.
    Lai, K. N.
    Lo, W. K.
    Lam, C. W.
    Yu, C. M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (03): : 516 - 516
  • [29] Markers of endothelial damage in patients with chronic kidney disease (vol 312, pg F673, 2017)
    Carmona, A.
    Agura, M. L.
    Luna-Ruiz, C.
    Buendia, P.
    Calleros, L.
    Garcia-Jerez, A.
    Rodriguez-Puyol, M.
    Arias, M.
    Arias-Guillen, M.
    de Arriba, G.
    Ballarin, J.
    Bernis, C.
    Fernandez, E.
    Garcia-Rebello, S.
    Mancha, J.
    del Peso, G.
    Perez, E.
    Poch, E.
    Portoles, J. M.
    Rodriguez-Puyol, D.
    Sÿnchez-Villanueva, R.
    Sarro, F.
    Torres, A.
    Martin-Malo, A.
    Aljama, P.
    Ramirez, R.
    Carracedo, J.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 314 (01) : F141 - F141
  • [30] ALBUMINURIA DURING AND AFTER PARICALCITOL TREATMENT IN CHRONIC KIDNEY DISEASE PATIENTS
    Ekart, Robert
    Hojs, Nina
    Bevc, Sebastjan
    Hojs, Radovan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 376 - 376